Press release
Global Hypertrophic Cardiomyopathy Therapeutics Market to Witness Sluggish Growth; to Register 1.4% CAGR 2015-2023
According to the American Heart Association, hypertrophic cardiomyopathy is a common condition that occurs when the muscle cells of the heart enlarge, causing the ventricle walls to thicken. HCM affects both men and women and is a common cause of sudden cardiac arrest in young people. The rising incidence of obstructive and non-obstructive hypertrophic cardiomyopathy is anticipated help the global market maintain a steady, albeit meager CAGR of 1.4% from 2015 to 2023. In 2014, the value of the hypertrophic cardiomyopathy therapeutics market was pegged at US$1.2 bn, which is forecast to increase to US$1.4 bn by 2023.
Download free exclusive Brochure of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7553
The global market for hypertrophic cardiomyopathy therapeutics has been studied on two fronts: By drug class and by geography.
Based on drug class, the hypertrophic cardiomyopathy therapeutics market has been categorized into calcium channel blockers, anticoagulants, beta adrenergic blocking agents, and antiarrhythmic agents. Although beta adrenergic blocking agents are the first preference for the treatment of obstructive as well as non-obstructive hypertrophic cardiomyopathy, calcium channel blockers form the largest segment in the overall market in terms of revenue. This can be attributed to the fact that the price of the latter blocking agents is much higher than that of the former.
By geography, the global hypertrophic cardiomyopathy therapeutics market comprises, Asia Pacific, North America, Europe, and Rest of the World. North America and Europe dominate the worldwide market, with the U.S. being the largest market for hypertrophic cardiomyopathy therapeutics. Accounting for a share of over 30% in 2014, the country is projected to retain is lead position throughout the forecast period. The hypertrophic cardiomyopathy therapeutics markets in Europe and North America are fueled by the rising prevalence of sedentary lifestyle among the younger population, the availability of modern healthcare infrastructure, and an increased presence of obesity. Growing awareness about hypertrophic cardiomyopathy and the various therapeutics available today has also significantly propelled the hypertrophic cardiomyopathy therapeutics market in these two regions.
View exclusive Global strategic Business report:
http://www.transparencymarketresearch.com/hypertrophic-cardiomyopathy-therapeutics-market.html
Asia Pacific is predicted to be the fastest expanding market by 2023, fueled primarily by the rapid development in healthcare infrastructure, the increasing prevalence of various chronic diseases, and the growing awareness about various cardiac complications.
The report offers a detailed section on the competitive landscape of the global hypertrophic cardiomyopathy therapeutics market. The strengths, weaknesses, opportunities, and threats of each of the profiled players have also been examined in the report. Some of the promising companies in the hypertrophic cardiomyopathy therapeutics market are Teva Pharmaceuticals Limited, Gilead Sciences, Inc., Merck & Co., Inc., AstraZeneca plc, Concordia Healthcare Corp., Pfizer, Inc., Mylan N.V., Novartis AG, and Sanofi S.A.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Hypertrophic Cardiomyopathy Therapeutics Market to Witness Sluggish Growth; to Register 1.4% CAGR 2015-2023 here
News-ID: 363837 • Views: …
More Releases from TMR – Research Reports
Power Line Communication Market to Present Highly Lucrative Opportunities for Ma …
Power Line Communication (PLC) is an emerging communication technology which enables data exchange over existing power cables. It uses power grids to communicate between two end-points. PLC technology allow users to control or retrieve data in a half-duplex manner. Furthermore, in this communication method, sender modulates the data, and injects in power cables which can be retrieved by de-modulation at the receiving end. PLC technology is widely used for home…
Wood Coatings Market - Roof coatings to Register High Demand | 2025
The global wood coatings market is choc-o-bloc with players and this has served to intensify the competition over the years. Product differentiation is a key tool leveraged by players to steal a march over their competitors. Key factors promoting growth in the market are the soaring construction activities across the globe and the increasing spending capacity of people which has stoked sales of furniture.
Another factor catalyzing growth in the global…
Welding Materials Market - Thriving Growth In Industrial Application Segments By …
The global welding materials market is growing on account of the thriving growth of application segments such as transportation, building and construction, marine, and automobiles. The growing urbanization in developing nations will drive the growth of this market. The increasing infrastructure development in Asia Pacific will also fuel the growth of the welding materials market. The technological advancements in the automobile industry will also aid the growth of this market.…
Intumescent Coatings Market Demand for Improved Fire Safety to Fuel Growth By 20 …
The global intumescent coatings market has remained moderately concentrated as nearly 45% of its overall share was held by three enterprises in 2015. These companies were Sherwin-Williams Co., PPG Industries Inc., and Nobel N.V., finds Transparency Market Research (TMR) in a new study. These companies, besides other prominent market players are continuously making efforts to expand their regional footprint by establishing new manufacturing units.
While expanding operations across emerging nations has…
More Releases for Hypertrophic
Rising Obesity Rates Fuel Growth In Hypertrophic Cardiomyopathy Treatment Market …
The Hypertrophic Cardiomyopathy Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Hypertrophic Cardiomyopathy Treatment Market Size and Projected Growth Rate?
The market size of treatment for hypertrophic cardiomyopathy has seen consistent growth in recent times. The size is projected to increase from…
Evolving Market Trends In The Hypertrophic Cardiomyopathy (HCM) Therapeutics Ind …
The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size and Its Estimated Growth Rate?
In the past few years, the hypertrophic cardiomyopathy (HCM) therapeutics market has seen a minor increase in its…
Evolving Market Trends In The Hypertrophic Cardiomyopathy (HCM) Therapeutics Ind …
The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Size and Its Estimated Growth Rate?
In the past few years, the hypertrophic cardiomyopathy (HCM) therapeutics market has seen a minor increase in its…
Key Hypertrophic Cardiomyopathy Treatment Market Trend for 2025-2034: Innovative …
What Is the Future Outlook for the Hypertrophic Cardiomyopathy Treatment Market's Size and Growth Rate?
The hypertrophic cardiomyopathy treatment market will grow from $1.37 billion in 2024 to $1.42 billion in 2025, at a CAGR of 4.2%. This growth is supported by advances in diagnostic technologies, drug therapies, surgical interventions, and clinical guidelines.
The Hypertrophic Cardiomyopathy Treatment market will grow to $1.72 billion by 2029 at a CAGR of 4.9%. Growth is…
Key Hypertrophic Cardiomyopathy Treatment Market Trend for 2025-2034: Innovative …
What Is the Future Outlook for the Hypertrophic Cardiomyopathy Treatment Market's Size and Growth Rate?
The hypertrophic cardiomyopathy treatment market will grow from $1.37 billion in 2024 to $1.42 billion in 2025, at a CAGR of 4.2%. This growth is supported by advances in diagnostic technologies, drug therapies, surgical interventions, and clinical guidelines.
The Hypertrophic Cardiomyopathy Treatment market will grow to $1.72 billion by 2029 at a CAGR of 4.9%. Growth is…
Hypertrophic Cardiomyopathy Market - Empowering Lives, Elevating Heart Health: H …
Newark, New Castle, USA: The "Hypertrophic Cardiomyopathy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hypertrophic Cardiomyopathy Market: https://www.growthplusreports.com/report/hypertrophic-cardiomyopathy-market/8833
This latest report researches the industry structure, sales, revenue,…
